A proposed sale of 7,020 CorVel (CRVL) shares covers stock an officer acquired by exercising options.
CorVel Corp. officer Maxim Shishin has filed a notice of proposed sale for 7,020 common shares of CRVL, valued at approximately $613,307.21, with an anticipated sale date of November 19, 2026. These shares were acquired by Shishin through a stock option exercise on the same date, using cash as the payment method. The filing indicates a neutral sentiment and impact on the stock.
Form 4 CorVel Corp: Mark E. Bertels (EVP - Risk Management Services) For: 16 November
This article reports on a Form 4 filing for CorVel Corp, specifically detailing a transaction by Mark E. Bertels, EVP - Risk Management Services, on November 16. It indicates that the filing is an update on insider trading activity for the company. The content primarily serves as a brief announcement of the filing without providing further details about the transaction itself.
CorVel Corp stock hits 52-week high at $89.88
CorVel Corp's stock has reached a new 52-week high of $89.88, reflecting a significant 48% surge in the past six months and 25.23% growth over the past year. Despite this strong performance, InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value. The company's market cap stands at $4.41 billion, indicating a substantial presence in the healthcare cost management sector.
CorVel Corp stock hits 52-week high at $89.88 By Investing.com
CorVel Corp (CRVL) stock has reached a new 52-week high of $89.88, trading at $89.74, nearly double its 52-week low. The company has seen a 48% surge in the last six months and a 25.23% increase over the past year. Despite this growth, InvestingPro analysis suggests the stock is currently overvalued.
Insider Selling: CorVel (NASDAQ:CRVL) VP Sells $181,608.00 in Stock
CorVel Corp. (NASDAQ:CRVL) VP Jennifer Yoss sold 2,100 shares of the company's stock on Friday, November 13th, for a total of $181,608.00 at an average price of $86.48 per share. This transaction reduced her holdings by 48.74% to 2,209 shares. The sale follows a previous transaction in August and comes as CorVel shares trade near their 52-week high, with the company reporting strong quarterly earnings.
An officer proposes selling 5,847 CorVel (CRVL) shares through Morgan Stanley Smith Barney.
CorVel Corporation (CRVL) officer Mark E. Bertels has filed a Form 144 notice proposing to sell 5,847 common shares with an aggregate market value of $511,612.50. The shares were acquired through a stock option exercise on November 16, 2026, and the proposed sale date is also November 16, 2026, with Morgan Stanley Smith Barney LLC acting as the broker. This filing provides details on the transaction and Bertels' relationship to the issuer.
CorVel (CRVL) officer Jennifer Yoss proposes selling 2,100 shares on approximately November 13.
CorVel Corporation (CRVL) officer Jennifer Yoss has filed a notice for a proposed sale of 2,100 common shares, with an aggregate market value of $181,612.83. The proposed sale date is November 13, 2026, and the shares were acquired through a cash stock option exercise on the same date. Yoss also reported a prior sale of 2,100 common shares on August 20, 2026, for gross proceeds of $148,921.50.
Form 4 CorVel Corp: Steven J. Hamerslag (Director) For: 11 November By Investing.com
This article reports on a Form 4 filing for CorVel Corp, indicating insider trading activity by director Steven J. Hamerslag on November 11. The filing provides transparency on transactions made by company insiders, which can be of interest to investors tracking corporate governance and stock performance.
Corvel Corp. director Steven Hamerslag sells $924,470 of CRVL stock By Investing.com
Steven J. Hamerslag, a director at CORVEL CORP (NASDAQ:CRVL), recently sold 11,000 shares of the company’s common stock for a total of $924,470. The transactions occurred on November 11, 2026, at a price of $84.0428 per share. Following these sales, Mr. Hamerslag still directly holds 276,000 shares of CORVEL CORP.
A director's trust sold CorVel (CRVL) shares with a $920,040 aggregate market value.
The Steven J. Hamerslag and Jean Wells Hamerslag Trust dated December 9, 1988, which lists CorVel director Steven J. Hamerslag as trustee, sold 11,000 common shares of CorVel (CRVL) on November 11, 2026. The aggregate market value of these shares was $920,040. This transaction was filed via a Form 144 with the SEC.
CorVel Director Steven J. Hamerslag Executes Rule 144 Sale of 11,000 Shares via Family Trust
CorVel Corporation director Steven J. Hamerslag completed a Rule 144 sale of 11,000 common shares through his family trust on November 11, 2026, as disclosed in a Form 144 filed on November 12, 2026. The shares, originally acquired in 2006 via stock options, were valued at $920,040 at the time of sale. J.P. Morgan Securities LLC handled the transaction.
Form 4 CorVel Corp: Mark E. Bertels (EVP - Risk Management Services) For: 5 November
This article reports on a Form 4 filing for CorVel Corp, specifically detailing a transaction involving Mark E. Bertels, EVP - Risk Management Services, on November 5. The content reiterates the headline multiple times and links to a Reuters image, indicating a standard corporate disclosure.
Form 4 CorVel Corp: Michael G. Combs (CEO & President) For: 6 November
This article reports on a Form 4 filing for CorVel Corp, detailing a transaction involving Michael G. Combs, the CEO & President. The filing pertains to activity on November 6. The article itself serves as a brief announcement of this regulatory disclosure.
Form 4 CorVel Corp: Maxim Shishin (Chief Information Officer) For: 5 November
This article reports on a Form 4 filing for CorVel Corp, indicating that Maxim Shishin, the Chief Information Officer, made a transaction on November 5th. The filing is a standard regulatory disclosure for insider trading. The article was published on November 10, 2026.
Form 4 CorVel Corp: Brian S. Nichols (CFO) For: 5 November By Investing.com
This article reports on a Form 4 filing for CorVel Corp, indicating an insider transaction by Brian S. Nichols, the company's CFO. The filing pertains to activity on November 5th. The article is a brief announcement without further details on the nature of the transaction.
Form 4 CORVEL CORP For: Nov 05 Filed by: Bertels Mark E.
Mark E. Bertels, EVP - Risk Management Services at Corvel Corp (CRVL), filed a Form 4 disclosing the acquisition of 6,000 non-qualified stock options. These options, with an exercise price of $85.91, were granted on November 5, 2026, and vest based on the achievement of specific earnings growth performance criteria. The expiration date for these options is November 5, 2031.
Form 144 CORVEL CORP For: 7 November By Investing.com
This article from Investing.com announces the filing of Form 144 for CORVEL CORP on November 7. Form 144 is a notice of the intent to sell restricted securities. The article provides the company's stock symbol CRVL and its current performance of -3.20%.
Form 144 CORVEL CORP For: 7 November By Investing.com
This article from Investing.com announces the filing of Form 144 for CORVEL CORP on November 7. Form 144 is a notice of the intent to sell restricted securities. The brief report serves as a factual notification of a corporate filing relevant to shareholders and potential investors.
CorVel Corp (CRVL) Q2 2027 Earnings Call Highlights: Revenue Tops $1 Billion Milestone as ...
CorVel Corp (CRVL) achieved a significant milestone in Q2 2027, with trailing 12-month revenue exceeding $1 billion for the first time, driven by an 11% year-over-year revenue increase to $267 million. The company reported expanded gross margins and improved earnings per share, attributing growth to increased claims volume, new customer wins, and strategic AI initiatives in claims management. Despite challenges like rising medical severity and claim complexity, CorVel maintains a debt-free balance sheet and strong cash flow, while expanding its payment integrity and pharmacy benefit management programs.
CorVel (CRVL) Could Be 31% Overvalued On Strong Quarterly Results
CorVel (CRVL) recently reported strong second-quarter results with US$267.1 million in revenue and US$34.1 million in net income, leading to a significant 5.74% stock price increase on the day and a 39.67% return over 90 days. Despite this positive momentum and a P/E ratio of 36.3x which is lower than direct peers, the company is considered overvalued by Simply Wall St's discounted cash flow model, suggesting a potential 31% overvaluation from a cash flow perspective.
Earnings Growth Could Be A Game Changer For CorVel Stock (CRVL)
CorVel (CRVL) reported strong fiscal Q2 2027 results with significant year-over-year growth in revenue and net income, driven by momentum in workers' compensation and liability services and increased use of AI in claims handling. The company's investment narrative centers on its ability to leverage technology to process claims more efficiently, although risks include its high P/E ratio and recent insider selling. Despite these factors, the Q2 report reinforces the company's operational strength and its strategic advantage in AI-powered claims administration.
Form 8K CorVel Corp For: 3 November By Investing.com
This article from Investing.com announces that CorVel Corp (CRVL) has filed a Form 8K for November 3rd. A Form 8K is a comprehensive report of unscheduled material events or corporate changes at a company that could be of importance to the shareholders or the U.S. Securities and Exchange Commission. The filing is available for public viewing, indicating transparency in the company's recent activities.
CorVel (NASDAQ:CRVL) Reaches New 1-Year High - Here's What Happened
CorVel (NASDAQ:CRVL) shares hit a new 52-week high of $85.79 on Tuesday, continuing to trade above its 50-day and 200-day moving averages. The company recently reported quarterly revenue of $267.13 million and earnings of $0.67 per share, while Weiss Ratings upgraded the stock from "hold (c-)" to "hold (c)". Insider transactions show sales totaling $630,420 in the last quarter, with institutional investors holding 51.36% and insiders 39.72% of the stock.
CorVel stock hits 52-week high at 85.24 USD
CorVel Corporation's stock has reached a new 52-week high of $85.24, with shares currently trading at $85.29. The company has shown strong performance with a 6-month gain of nearly 45% and a year-to-date increase of 23%. Despite appearing overvalued according to InvestingPro, CorVel maintains a "GREAT" financial health score and recently reported a significant rise in quarterly earnings and revenue.
CorVel quarterly revenue rises 11% to $267m
CorVel Corporation reported an 11% year-over-year increase in revenue, reaching $267 million for its fiscal second quarter ending September 30, 2026. The company also saw diluted earnings per share grow by 24% to $0.67 and gross profit increase by 24% to $72.3 million. CorVel maintained a strong financial position with $270 million in cash and no borrowings, after repurchasing $18.1 million of its common stock.
Corvel Corp (CRVL) Tops Q3 EPS by 67c
Corvel Corp (CRVL) announced its Q3 earnings, reporting an EPS of $0.67. The company's revenue for the quarter reached $267.13 million. This performance led to a positive movement in its stock price, which was up 2.78% at $85.54.
Form 8K CorVel Corp For: 3 November By Investing.com
This article announces that CorVel Corp (CRVL) filed a Form 8K on November 3, 2026. The filing is a standard regulatory disclosure and is likely to contain important company information. The stock symbol CRVL is noted as having increased by 5.74%.
Revenue rises 11% at CorVel (CRVL) as per-share earnings grow faster.
CorVel Corporation reported an 11% increase in second-quarter fiscal 2027 revenue, reaching $267.129 million, with diluted earnings per share rising 24% to $0.67. The company highlighted strong performance in its workers' compensation and liability businesses, driven by new customer acquisitions and enhanced client relationships. CorVel also emphasized technological advancements, including AI integration in claims workflows and strategic partnerships to expand market access for its CERIS platform.
CorVel Corp. (CRVL) Stock forecasts
CorVel Corp. (CRVL) recently had its target price raised to $91.00 by Argus on October 28, 2026. The company, which utilizes AI and machine learning to manage healthcare costs, is currently trading at $83.23. The report suggests an upgrade to access more premium tools and detailed insights.
CorVel Corp. (CRVL) Stock Forecasts
CorVel Corp. (CRVL) is a financial services company that utilizes AI, machine learning, and natural language processing to manage healthcare costs. Argus has raised its target price for CRVL to $83.00, aligning with the current price of $83.23. The company's report was published on October 7, 2026.
CorVel Corp. Estimates – NASDAQ:CRVL
This page on TradingView provides financial estimates and actuals for CorVel Corp. (NASDAQ: CRVL). Users can explore reported financial data and analyst estimates across various financial statements, compare actual results with average, high, and low estimates, and visualize trends over time. The platform offers detailed views of the income statement, balance sheet, and cash flow, both annually and quarterly.
CorVel Corp. (CRVL) Stock forecasts
An Argus report from October 21, 2026, has raised the target price for CorVel Corp. (CRVL) to $89.00 from its current price of $83.87. The report highlights CorVel Corp.'s application of technology, including AI, machine learning, and natural language processing, to improve healthcare cost management. This analysis is part of broader financial reporting that includes other stock forecasts.
CorVel Corp. (CRVL) Stock forecasts
Argus has raised its target price for CorVel Corp. (CRVL) to $89.00, citing the company's application of advanced technologies like AI, machine learning, and natural language processing to manage healthcare costs. The current price of CRVL is $83.88.
CorVel Corp stock hits 52-week high at 83.58 USD
CorVel Corp's stock has reached a new 52-week high of $83.58, showing significant growth over the past six months and year-to-date. Despite this, InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value. The company also recently reported an 11% increase in Q1 2026 revenue to $260 million and a 22% rise in earnings per share to $0.63.
CorVel Corp stock hits 52-week high at 83.58 USD By Investing.com
CorVel Corp's stock has reached a new 52-week high of $83.58, showing significant gains over the last six months and year-to-date, although InvestingPro analysis suggests it is overvalued. The company also reported strong Q1 2026 financial results with increased revenue and earnings per share, and shareholders re-elected six directors.
Assenagon Asset Management S.A. Sells 29,251 Shares of CorVel Corp. $CRVL
Assenagon Asset Management S.A. reduced its stake in CorVel Corp. (NASDAQ:CRVL) by 28.7% in the third quarter, selling 29,251 shares and retaining 72,701 shares valued at $5.42 million. CorVel shares traded at $81.31, close to their 12-month high, with a market capitalization of $4.15 billion. Institutional investors hold 51.36% of the stock, while insiders, who recently sold 8,947 shares, own 39.72%.
Form 4 CorVel Corp: Michael G. Combs (CEO & President) For: 30 September By Investing.com
This article reports on a Form 4 filing for CorVel Corp, detailing an insider transaction by Michael G. Combs, the CEO & President, for the period ending September 30. The brief notice from Investing.com indicates that the filing is a standard disclosure of executive stock activity.
Form 4 CorVel Corp: Michael G. Combs (CEO & President) For: 30 September
This article reports on a Form 4 filing for CorVel Corp, detailing transactions made by Michael G. Combs, the CEO & President. The filing pertains to activity on September 30. The article is a brief notification of this insider trading report.
Form 4 CorVel Corp: Michael G. Combs (CEO & President) For: 30 September
This article reports on a Form 4 filing for CorVel Corp, specifically detailing the activities of CEO & President Michael G. Combs for September 30. It focuses on the corporate insider transaction, which is a required filing for company officers, directors, or beneficial owners of more than ten percent of a company's stock.
33,468 CorVel Corp. $CRVL Shares Sold by Curated Wealth Partners LLC
Curated Wealth Partners LLC significantly reduced its stake in CorVel Corp. (NASDAQ:CRVL) by selling 33,468 shares, an 82.2% cut, leaving them with 7,232 shares valued at $539,000. Despite this sale, institutional ownership in CorVel remains high at 51.36%, with major investors like BlackRock and Algert Global increasing their positions. The company's stock opened at $79.69, near its 52-week high, and reported quarterly revenue of $259.93 million with earnings of $0.63 per share.
Total current assets of CorVel Corp. – NASDAQ:CRVL
The article provides a financial data point for CorVel Corp. (NASDAQ: CRVL), specifically its total current assets. It indicates the period, value, and percentage change of these assets, noting that the data is provided by ICE Data Services and FactSet.
CorVel Corp. (CRVL) Stock Forecasts
This article provides an Argus research report on CorVel Corp. (CRVL), a company that utilizes AI, machine learning, and natural language processing to manage healthcare costs. Argus has raised its target price for CRVL to $87.00 from the current price of $80.29. The report suggests upgrading to premium services for detailed insights into CRVL and other related companies.
CorVel Corp stock hits 52-week high at 79.54 USD By Investing.com
CorVel Corp's stock has reached a 52-week high of $79.54, driven by a 43% surge in the last six months and strong financial performance in the June quarter of 2026. The company reported a 22% increase in earnings per share and an 11% rise in revenue. While the stock is trading near its Fair Value, InvestingPro Tips indicate it may be in overbought territory.
CorVel Corp stock hits 52-week high at 79.54 USD By Investing.com
CorVel Corp (CRVL) stock reached a 52-week high of $79.54, reflecting strong performance with a 43% surge over the past six months and a 10.63% increase over the past year. InvestingPro analysis indicates the stock is trading near its Fair Value and 52-week high, though the RSI suggests it might be overbought. The company recently reported a 22% rise in EPS and an 11% increase in revenue for the June quarter of 2026, alongside re-electing six directors.
CorVel (NASDAQ:CRVL) Reaches New 1-Year High - Time to Buy?
CorVel (NASDAQ:CRVL) recently reached a new 52-week high of $79.43, with a market capitalization of $4.03 billion. Despite positive financial performance, including a net margin of 11.72% and a return on equity of 29.92%, analyst sentiment remains cautious with a "Hold" rating. Insider selling has occurred, but institutional investors and hedge funds own over 51% of the company's stock.
CorVel Corp stock hits 52-week high at 79.54 USD
CorVel Corp's stock has reached a 52-week high of $79.54, reflecting a 43% surge over the past six months and a 10.63% increase over the past year. The company's strong performance is supported by a 22% rise in earnings per share and an 11% increase in revenue for the June quarter of 2026. InvestingPro analysis indicates the stock is trading near its Fair Value, though the RSI suggests it may be in overbought territory.
CorVel Corp stock hits 52-week high at 79.54 USD By Investing.com
CorVel Corp stock recently hit a 52-week high of $79.54, reflecting a 10.63% positive change over the past year and a 43% surge in the last six months. InvestingPro analysis indicates the stock is trading near its Fair Value but suggests it might be in overbought territory. The company also reported strong Q2 2026 financial results with a 22% EPS increase and an 11% revenue rise, alongside the re-election of six directors at its annual meeting.
CorVel Corp. (CRVL) Stock Forecasts
Argus has raised its target price for CorVel Corp. (CRVL) to $82.00, citing the company's application of AI, machine learning, and natural language processing to manage healthcare costs. The current price of CRVL stock is $78.81. The report suggests an upgrade to premium research for more detailed insights.
Form 4 CorVel Corp For: 2 October By Investing.com
This article from Investing.com reports on a Form 4 filing for CorVel Corp (CRVL) on October 2, 2026. Form 4s disclose transactions by company insiders, but the article does not provide specific details about the transactions. It appears to be a brief notification of the filing.
Form 4 CorVel Corp For: 1 October By Investing.com
This article reports on a Form 4 filing for CorVel Corp (CRVL) dated October 1. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a material change in the holdings of company insiders. The article includes a stock symbol and its current performance.